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B

loodstream infections (BSIs) are the third most common
cause of hospital mortality and are the 7th and 11th leading
cause of all U.S. deaths for infants and adults, respectively (1, 2). In
a 7-year cohort study of 49 U.S. hospitals reported in 2004, mortality rates directly attributable to BSIs were estimated to be between 16% and 40%. According to surveillance data from U.S.
hospitals, 87% of BSIs are caused by a single infecting microorganism, with Gram-positive bacteria accounting for 65% of BSIs,
Gram-negative bacteria for 25%, and fungi for 9.5% (3).
The current gold standard for diagnosing bloodstream infections utilizes automated blood culturing, usually performed on at
least two separate blood draws taken at different times (4, 5). Studies have found that the sensitivity of blood culturing is between
65% and 96%, depending on the number of cultures taken and the
volume of blood obtained for each culture. Within 5 days of
growth, 99% of BSIs can be detected using Bactec blood culturing
bottles (6). Automated blood culture systems can detect as few as
1 CFU/ml, while molecular methods have demonstrated limits of
detection between 10 and 100 CFU/ml (1, 7).
While these characteristics are certainly benefits of conventional blood culture, a major weakness is that it requires an extended amount of time for the organism(s) to grow to detectable
levels and then for isolation and identification (ID) of the organism(s). One study found that the culturing time required for bacteria to grow to levels detectable by an automated instrument
averaged 12 to 24 h for Gram-negative organisms and 24 to 48 h
for Gram-positive organisms (7). A separate study of neonates at
the Magee Women’s Hospital in Pittsburgh, PA, determined that
the mean time to detect bacterial growth using an automated
blood culture instrument was 18 h (range, 11 to 28 h), while the
mean time to complete the organism’s final identification was 49 h
(range, 23 to 73 h) (8).
The relatively long time required to diagnose a BSI using cur-
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rent methods presents a significant challenge given the small window in which effective antibiotic treatment can be successfully
administered and the public health risk associated with administering ineffective and/or unnecessary antibiotics. A number of potential molecular methods of diagnosis, including the use of PCR
assays and nucleotide sequencing, have been investigated as a way
to address this issue.
Significant success has been seen using PCR protocols in neonates, who typically have higher bacterial loads (9) and fewer bacterial species causing sepsis than adult populations (8). Studies
using real-time PCR to amplify universal sequences of the 16S
rRNA gene were shown to have high sensitivity and specificity, as
well as a very high negative predictive value (99.2%) when used in
neonatal populations (7, 10). The high negative predictive value of
the PCR assay means that a negative result can be obtained within
hours, not days, thus leading to a significant reduction in the duration of unnecessary antibiotic therapy (11).
Pyrosequencing is a valuable tool used in conjunction with
PCR to diagnose BSIs and can eliminate the 1 to 2 additional days
needed to isolate the organism for phenotypic identification. Previous studies combining real-time PCR and pyrosequencing have
been successful in identifying bacteria in blood culture bottles
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Conventional blood culturing using automated instrumentation with phenotypic identification requires a significant amount of
time to generate results. This study investigated the speed and accuracy of results generated using PCR and pyrosequencing compared to the time required to obtain Gram stain results and final culture identification for cases of culture-confirmed bloodstream infections. Research and physician-ordered blood cultures were drawn concurrently. Aliquots of the incubating research
blood culture fluid were removed hourly between 5 and 8 h, at 24 h, and again at 5 days. DNA was extracted from these 6 time
point aliquots and analyzed by PCR and pyrosequencing for bacterial rRNA gene targets. These results were then compared to
those of the physician-ordered blood culture. PCR and pyrosequencing accurately identified 92% of all culture-confirmed cases
after a mean enrichment time of 5.8 ⴞ 2.9 h. When the time needed to complete sample processing was included for PCR and
pyrosequencing protocols, the molecular approach yielded results in 11.8 ⴞ 2.9 h compared to means of 27.9 ⴞ 13.6 h to obtain
the Gram stain results and 81.6 ⴞ 24.0 h to generate the final culture-based identification. The molecular approach enabled accurate detection of most bacteria present in incubating blood culture bottles on average about 16 h sooner than Gram stain results
became available and approximately 3 days sooner than the phenotypic identification was entered in the Laboratory Information
System. If implemented, this more rapid molecular approach could minimize the number of doses of unnecessary or ineffective
antibiotics administered to patients.

PCR Detects Bacteria Sooner than Automated Instrument

TABLE 1 Primer sequences used for analysis of bacterial rRNA genes
Organism
group

rRNA gene
target
Real-time PCR primer seta (5=–3=)

Staphylococcus 16S
Streptococcus
23S
Enteric
23S
Universal

16S

B

Pyrosequencing primer(s)b (5=–3=)

F , TGCCTAATACATGCAAGTCGAGCG; R, GTTGCCTTGGTAAGCCGTTACCTT
FB, GCCTTTTGTAGAATGAACCGGCGA; R, CGTTTGGAATTTCTCCGCTACCCA
F1, CTAAGGCGAGGCCGAAAG; F2, CTAAGGCGAGGCTGAAAAG; RB,
CTACCTGACCACCTGTGTCG
FB, AACTGGAGGAAGGTGGGGAT; R, AGGAGGTGATCCAACCGCA

GTGTTACTCACCCGTCCGCCGCTA
TCACATGGTTTCGGGTCTA
S1, GGTTGTCCCGGTTTA; S2,
GGTCGTCCCGGTTCA
TACAAGGCCCGGGAACGTATTCA

a

FB, biotinylated forward primer; R, reverse primer; RB, biotinylated reverse primer; F1 and F2, degenerate forward primers used in combination.
b 1
S and S2, degenerate pyrosequencing primers used in combination.

MATERIALS AND METHODS
Enrollment. This study was designed as a prospective, observational study
in an urban academic emergency department (ED) and intensive care unit
(ICU). Participants were eligible if they had a physician-ordered blood
culture and a complete blood count (CBC) sample drawn. A total of 1,144
eligible study participants were provided information about the study by
clinical staff and consented to participate. Potential participants were excluded from the study if they declined to participate or if a blood sample
could not be obtained. This study describes the results from the subset of
participants with culture-confirmed BSIs. The Institutional Review Board
of The George Washington University (GWU) and Medical Center, Office
of Human Research approved this study.
Automated blood culturing and phenotypic identification. Blood (8
to 10 ml) for conventional culture was collected by either a venous or
arterial draw and inoculated directly into one each of a BD Bactec Plus
Aerobic/F medium blood culture bottle (catalog no. 442192; Becton,
Dickinson [BD], Sparks, MD) and a standard Anaerobic/F medium blood
culture bottle (catalog no. 442191; BD). Physician-ordered blood cultures
were drawn and sent to the hospital clinical microbiology lab for routine
blood culture performed using a Bactec 9240 bottle (BD). Each bottle was
loaded into the Bactec 9240 automated blood culture instrument within 1
h from the time of receipt in the clinical laboratory in accordance with the
manufacturer’s recommendation.
Bottles flagged by the instrument for detectable levels of CO2 production had fluid removed for Gram staining and subculturing onto appropriate agar-based culture plates. Purified bacterial colonies were analyzed
either by an automated identification system (Vitek 2; bioMérieux, Durham, NC) or with the appropriate biochemical reagents for manual phenotypic identification.
Research blood sample incubation. The entire 8 to 10 ml of the research blood sample, drawn at the same time as the routine clinical blood
sample using the same needle stick, was collected in a tube containing
sodium polyanethole sulfonate-sodium chloride (catalog no. 364960; BD)
was inoculated in a Bactec Plus Aerobic/F blood culture bottle (BD catalog
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no. 442192) and then immediately placed in a shaking incubator at 37°C
and 150 rpm (Excella E24 incubator shaker series; New Brunswick Scientific, Enfield, CT). The time of inoculation was noted, and beginning at 5
h after inoculation and for every subsequent hour through 8 h, again at 24
h, and after 5 days, 1.5-ml aliquots of blood were removed aseptically for
DNA extraction. At the terminal 5-day time point, a blood smear for
Gram staining was also prepared, air dried, heat fixed, and stained. In all,
aliquots at 6 time points were removed from each incubating research
blood culture bottle for DNA extraction, PCR, and pyrosequencing.
Blood samples were rejected if the blood was grossly hemolyzed and/or
clotted or if the volume of blood was inadequate.
DNA extraction of blood culture fluids obtained from time point
aliquots. DNA was extracted from each of the six time point aliquots
removed from the incubating blood culture bottle. Five hundred microliters of blood was centrifuged for 5 min at 5,000 ⫻ g at room temperature
(RT), and the resulting supernatants were discarded, after which 100 l of
5 mM guanidinium-HCl in 100 mM Tris-HCl (pH 8.0) was added to
resuspend each pellet. The resuspended samples were added to 0.24 g
0.1-mm zirconium silica beads (catalog no. 11079101z; Biospec Products,
Bartlesville, OK) and vortexed for 5 min. To each sample was added 400 l
distilled H2O (dH2O) and 800 l 99% benzyl alcohol, followed by centrifugation for 5 min at 5,000 ⫻ g. The aqueous supernatant was retained,
and this extraction step was repeated. Next, a 1/10 volume of 3 M sodium
acetate (NaOAC) and an equal volume of 99% isopropyl alcohol and 1 l
glycogen were added to each sample, and the samples were centrifuged for
15 min at 4°C and 13,000 ⫻ g. The pellets were washed with 100 l 70%
ethanol (EtOH) and centrifuged for 5 min at 4°C and 13,000 ⫻ g. The
supernatant was removed, and the pellets were allowed to air dry. Once
they were dry, 50 l of 1⫻ TE (10 mM Tris-HCl [pH 8.0], 1 mM EDTA)
was added to each pellet.
Real-time PCR. DNA extracts generated from the 6 time point aliquots were screened by PCR using slightly modified sequences from previously published primers (Table 1) (10, 12), including a 16S rRNA gene
universal target and, when applicable, either a Staphylococcus 16S rRNA
gene, Streptococcus 23S rRNA gene, or enteric Gram-negative rod (GNR)
23S rRNA gene target(s). PCR mixtures of 25 l were set up, with 0.5 l
each of 10 M concentrations of the forward and reverse primers (one
primer of each pair was biotinylated), 12.5 l of 2⫻ SYBR Premix Ex Taq
polymerase master mix (catalog no. RR420A; TaKaRa Biotechnology, Dalian Corp., Ltd.), and 5 l of each DNA extract. PCR cycling conditions for
the universal, Staphylococcus, and Streptococcus targets consisted of 95°C
for 60 s, then 40 cycles of 95°C for 20 s, 60°C for 60 s, and 72°C for 15 s.
Cycling conditions for the enteric Gram-negative rod target consisted of
95°C for 120 s, then 40 cycles of 95°C for 20 s and 62°C for 30 s. All PCR
testing was performed using Smart Cycler instruments (Cepheid Inc.,
Sunnyvale, CA). An appropriate positive control for each group was included: 1 l DNA extracts from purified isolates of either Staphylococcus
aureus or coagulase-negative Staphylococcus species (CoNS) (Staphylococcus target), Streptococcus pneumoniae or an Enterococcus sp. (Streptococcus
target), or Escherichia coli or Klebsiella pneumoniae (enteric Gram-negative rod target). Any of the above bacterial DNA extracts served as a positive control for the universal target. Two no-template negative controls,
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from both infants and adults that demonstrate detectable growth.
One such study found an overall agreement of 97.8% between
molecular and culture-based methods of diagnosis, with a slightly
better agreement (98.8%) when infections were monomicrobial
(12).
In this study, we assessed whether screening blood culture fluids in the first few hours of their incubation would permit more
rapid detection of culture-confirmed bacterial BSIs than conventional automated blood culturing. To that end, we investigated the
accuracy and speed of our molecular approach in identifying the
microorganism(s) in cases of culture-confirmed BSIs and compared the times required to the times required to obtain the Gram
stain result and final culture identification.
(M. S. Moore completed this work for her senior thesis in partial fulfillment of the requirements for the degree of bachelor of
science at Georgetown University, Washington, DC.)

Moore et al.

RESULTS

Description of bacteria present in culture-confirmed cases of
bloodstream infections. One hundred bacterial isolates were cultured from 97 blood culture bottles obtained from 95 enrolled
participants. There were 3 polymicrobial infections (2 from the
ED and 1 from the ICU). Culture-confirmed cases containing
strict anaerobes or yeast were not included in this evaluation. The
100 blood culture isolates included 51 Staphylococcus sp. isolates
(19 S. aureus isolates and 32 CoNS sp. isolates), 28 Streptococcus
sp. isolates (8 Enterococcus sp. isolates, 5 S. pneumoniae isolates, 5
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viridans group streptococcal isolates, 4 group G Streptococcus
[GGS] isolates, 2 group A Streptococcus [GAS]isolates, 2 group B
Streptococcus [GBS]isolates, and 2 group C Streptococcus [GCS]
isolates), 15 enteric Gram-negative rod isolates (8 E. coli isolates
and 1 isolate each of K. pneumoniae, Serratia marcescens, Providencia rettgeri, Enterobacter aerogenes, Citrobacter freundii, Proteus
mirabilis, and a Salmonella sp.), 5 nonfermentative Gram-negative
rod isolates (4 Pseudomonas aeruginosa isolates and 1 Stenotrophomonas maltophilia isolate), and 1 Bacillus sp. isolate (not Bacillus
anthracis).
Of the 97 positive blood culture bottles, 47 (48.5%) originated
from ED patients, while 50 (51.5%) were from the ICU. One hundred percent (10/10) of the blood cultures containing S. pneumoniae or viridans group streptococci and 80% (12/15) of blood
cultures containing an enteric Gram-negative rod originated from
participants enrolled in the ED, while 87.5% (7/8) of all Enterococcus spp. and 75% (3/4) of P. aeruginosa isolates came from
blood cultures originating from participants in the ICU.
The molecular approach demonstrated a high rate of agreement with conventional automated blood culturing for detecting and classifying bacteria. There was 92% (92/100) agreement
between the molecular approach and phenotypically based culture ID (Table 2), with 98% agreement (50/51) for Staphylococcus
spp., 96.4% (27/28) for Streptococcus spp., 73.3% (11/15) for enteric Gram-negative rods (GNRs), 80% (4/5) for nonfermenting
GNRs, and 100% (1/1) for the Bacillus sp.
Of the 8 discordant results, 6 were from blood cultures containing GNRs, including 4 enteric GNR and 2 nonfermentative
GNR species not detected by the molecular approach; the former
4 samples were not detected by either the 16S rRNA gene universal
primer set or the 23S rRNA gene enteric GNR-specific primer set,
while the latter 2 samples were not detected by the universal
primer set. Three of these 6 (50%) discordant results were from
blood cultures containing polymicrobial growth. Presence of PCR
inhibitors was ruled out by performing PCR on these time point
aliquot DNA extracts spiked with 1,000 CFU/ml of purified bacterial DNA using the 16S rRNA gene universal primer set (data not
shown).
PCR/pyrosequencing was also performed on 300 DNA extracts
generated from sets of 6 time point aliquots of 50 culture-negative
specimens using the universal 16S rRNA gene primer set. These
blood cultures were obtained from the same patient population
(ED or ICU) as the other samples tested in this study. All 300 DNA
extracts tested were negative for bacterial DNA (data not shown).
Most bacteria within the research blood culture bottles from
culture-confirmed BSIs were first detected at the 5-h time point.
Figure 1 illustrates the percent distribution of the first time point
aliquot in each set that was found to be positive for bacteria using
the molecular approach. The results clearly show that the majority
(72.8%, 67/92) of bacteria from the 92 concordant culture-confirmed cases of BSI were first detected and correctly classified in
DNA extracts made after 5 h of enrichment. After 8 h, 93.5%
(86/92) of culture-confirmed cases were detected and accurately
classified, with only 6.5% (6/92) requiring more than 8 h for detection. Because it was not feasible to collect hourly time points
between 8 h and 24 h, the specific incubation time required for this
subset of samples is unknown. Three isolates were first detected
from the 24-hour-time-point aliquot (one each of S. aureus, S.
marcescens, and P. rettgeri), while 3 were detected only from the
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one at the beginning and one at the end, were also included in each PCR
run.
Pyrosequencing. The resulting 25 l of biotin-labeled PCR product
was immobilized onto 5 l of streptavidin-Sepharose high-performance
beads (catalog no. 17-5113-01; GE Healthcare, Little Chalfont, United
Kingdom) suspended in 50 l of binding buffer (catalog no. 979006;
Qiagen, Germantown, MD) in a deep-well plate (catalog no. NC9650319;
Phenix Research Products, Candler, NC) that was placed on a Thermomixer (catalog no. 5350 24744; Eppendorf AG, Hamburg, Germany) and
shaken at 1,400 rpm for 10 min at RT. Using the pyrosequencing vacuum
prep tool (catalog no. 9001516; Qiagen), the beads were immersed in 70%
EtOH, followed first by 0.2 M NaOH and then by wash buffer (catalog no.
979008; Qiagen). The resulting single-stranded biotinylated PCR product
was bound to beads and transferred into another deep-well plate containing 2 l of 10 M sequencing primer (Table 1) along with 38 l annealing
buffer (catalog no. 979009; Qiagen) in each well. The deep-well plate was
placed in a heated shaker (1,400 rpm) at 90°C for 1 min, followed by RT
for 5 min to allow complementary strands to anneal. The prep tool carried
the beads containing the single-stranded biotinylated PCR productprimer hybrid through 70% EtOH followed by wash buffer (catalog no.
979008; Qiagen) before being transferred into a low-well plate (catalog
no. 979002; Qiagen) containing 40 l of annealing buffer (catalog no.
979009; Qiagen) in each well. The plate containing the prepared sample
was analyzed using the PyroMark ID pyrosequencer (Qiagen) with PyroMark Gold Q96 reagents (catalog no. 972804; Qiagen) and a dispensation
program of either an 11(ACTG) deoxynucleoside triphosphate (dNTP)
for universal, Staphylococcus, and Streptococcus rRNA gene targets or an
AGC-12(CTGA) dNTP for the enteric rod rRNA gene target. Using PyroMark Identifire v1.0.5.0 software, the resulting sequences were compared
to our reference library (8, 10, 12), which included validated sequences
from previously identified clinical isolates, ATCC reference sequences,
and sequences found in the NCBI GenBank using the BLAST algorithm
(8, 10, 12). One hundred percent identity was required to make a genus or
species level identification.
Calculating the time required to obtain results using the molecular
approach and time saved compared to conventional automated blood
culturing. For each set of DNA extracts generated from the time point
series, we recorded the first time point aliquot of the six tested that was
positive by real-time PCR and pyrosequencing. This information was
used to determine the mean enrichment time needed to obtain a positive
result. A generous estimate of 6 h was used to reflect the additional time
needed to complete sample processing, PCR, and pyrosequencing, which
reflected the time required to process the six time point aliquots from one
participant. The sum of the mean enrichment time plus 6 h was used to
calculate the total time needed for this molecular approach. The time
required for a clinical diagnosis of BSI using conventional automated
blood culturing was based on electronic medical record data and included
the dates and times of the physician-ordered blood draw for culture and
of the telephone call made to the unit with the Gram-stain result and lastly
the date when the final identification was entered into the laboratory
information system (LIS); the software used by the hospital records only
the date, and not time, when the final identification is entered into the LIS.
When comparing the times required, a two-tailed t test was utilized to
assess statistical significance.

PCR Detects Bacteria Sooner than Automated Instrument

TABLE 2 Number and percent of results in agreement, disagreement, or undetected using the molecular method compared to the corresponding
physician-ordered automated blood culture resulta
Agreement
Total nb

Primer grouping
c

Staphylococcus spp.
Streptococcus spp.e
Enteric GNRsg,h
Universal onlyj
All

51
28
15
6
100

n
50
27
11
4
92

Disagreement
%

n

98.0
96.4
73.3
66.7
92

d

1
1f
0
0
2

Not detected
%

n

%

0.0
3.6
0.0
0.0
2.0

0
0
4i
2
6

2.0
0.0
26.7
33.3
6.0

5-day-time-point aliquot (one each of an E. coli, CoNS, and Enterococcus faecium).
The molecular approach provided bacterial identification
from culture-confirmed bloodstream infections sooner than
did the Gram stain or phenotypic culture. The overall mean enrichment time needed to detect bacteria using the molecular
approach was 5.8 ⫾ 2.9 h and ranged from 5.0 ⫾ 0.2 h to first
detect Streptococcus spp. to 7.1 ⫾ 5.7 h to first detect enteric
GNRs (Table 3).
Calculating total turnaround times (TAT) to detect and classify
bacteria using molecular testing included a generous estimate of 6
h in order to complete DNA extraction, PCR, and pyrosequencing
protocols. This resulted in an overall mean total TAT of 11.8 ⫾ 2.9
h; mean total TAT ranged from 11.0 ⫾ 0.2 h for Streptococcus spp.
to 13.1 ⫾ 5.7 h for enteric GNRs. In contrast, Gram stain results
took an average of 27.9 ⫾ 13.6 h to be called to the hospital unit,

ranging from 20.3 ⫾ 7.5 h for the enteric GNRs to 31.8 ⫾ 12.9 h
for Staphylococcus spp. Phenotypic identification took an average
of 3.4 days to be entered into the LIS. The molecular approach
allowed for a more specific bacterial classification ⬃16 h sooner
than the less informative Gram stain result and ⬃3 days sooner
than the conventional phenotypic culture-based ID. Based on a
two-tailed t test, there was a statistically significant decrease in the
time required for the molecular approach to generate an identification compared to the Gram stain result for all organisms (P ⬍
0.001) as well as for each specific grouping of bacteria (Table 3).
Gram stain results generated from the clinical bottles were
compared to those obtained from the terminal 5-day-time-point
aliquot of the research samples. There was perfect correlation between the clinical and research Gram stain results from the 92
concordant cases (data not shown). Between the two discordant
samples (Table 2) in which DNA sequences either generated a
different ID (GGS versus GCS using the Streptococcus-specific target) or did not match any known sequences in the library (S.
aureus using the Staphylococcus-specific target), there was concordance between the clinical and research Gram stain results—
Gram-positive cocci either in chains or clusters were observed
(data not shown). In contrast, in the 6 research samples where the
molecular approach did not detect any organisms, no bacteria
were seen in the Gram stains of the blood smears from the 5-daytime-point aliquots (data not shown).
DISCUSSION

FIG 1 Bar graph depicting the percentages, cumulative percentages, and
numbers of isolates detected at the indicated time points by the molecular
method from culture-confirmed blood culture samples.
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This study, which focused primarily on a subset of participants
with culture-proven BSIs, found that the molecular approach was
significantly faster at detecting BSIs than a conventional culturebased approach, while still maintaining a high degree of accuracy.
A 2006 study by Kumar et al. found that in a critically ill ICU
population, every hour of delay in administering antibiotic therapy resulted in a 7.6% decrease in survival rate (15). A study by
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a
Numbers and percentages of the 100 isolates detected by PCR/pyrosequencing using a target-specific and/or universal primer set(s). Purified isolates were available for all 8
discordant samples; DNA extracts were analyzed using PCR/pyrosequencing, and all isolates were correctly identified using both the universal and target-specific primer sets (data
not shown).
b
n, number of isolates.
c
Results for correct identification of Staphylococcus spp. are as follows: S. aureus (including both methicillin-sensitive S. aureus [MSSA] and methicillin-resistant S. aureus [MRSA]),
18/19 isolates (94.7%); CoNS, 32/32 isolates (100%).
d
While the universal primer set correctly classified the organism as a Staphylococcus sp., the DNA sequences generated using the Staphylococcus-specific primers failed to match any
known sequence in our library or the GenBank database.
e
Results for correct identification of Streptococcus and Enterococcus spp. (n ⫽ 28) are as follows: GAS, 2/2 isolates (100%); GBS, 2/2 isolates (100%); GCS, 2/2 isolates (100%); GGS,
3/4 isolates (75%); Enterococcus spp., 8/8 isolates (100%); S. pneumoniae, 5/5 isolates (100%); viridans group streptococci, 5/5 isolates (100%).
f
Culture-based identification was GGS. While the universal primer set correctly classified the organism as a Streptococcus sp., the Streptococcus-specific primer set identified the
organism as GCS. The difference in classification between GGS and GCS was a single base in the 233-bp region of the Streptococcus-specific 23S rRNA gene target being amplified.
g
GNRs, Gram-negative rods.
h
Results for correct identification of enteric GNRs (n ⫽ 15) are as follows: E. coli, 6/8 isolates (75%); Enterobacter/Citrobacter spp., 2/2 isolates (100%); S. marcescens, 1/1 isolate
(100%); Salmonella sp., 1/1 isolate (100%); P. rettgeri, 1/1 isolate (100%); P. mirabilis, 0/1 isolate (0%); K. pneumoniae, 0/1 isolate (0%).
i
PCR/pyrosequencing reactions from both the universal primers and the enteric GNR primers failed to detect 2 E. coli isolates and 1 isolate each of P. mirabilis and K. pneumoniae.
j
Results for correct identification using the universal target only (n ⫽ 6) are as follows: P. aeruginosa, 3/4 isolates (75%); Bacillus sp., 1/1 isolate (100%); S. maltophilia: 0/1 isolate
(0%).

Moore et al.

TABLE 3 Mean times required to obtain first positive molecular result compared to mean times required to obtain Gram stain result or final
identification from corresponding physician-ordered blood culture
Result (mean h ⫾ SD) for:
PCR/pyrosequencing

Physician-ordered blood culture

Bacterial grouping

First positive time
pointd (n ⫽ 89)

TATb for MDxc
IDd (n ⫽ 89)

TAT for Gram staine
(n ⫽ 76)

TAT for phenotypic culture
ID (n ⫽ 92)

P by t test

Staphylococcus spp.
Streptococcus spp.
Enteric GNRsa
All bacteria

5.9 ⫾ 2.8
5.0 ⫾ 0.2
7.1 ⫾ 5.7
5.8 ⫾ 2.9

11.9 ⫾ 2.8
11.0 ⫾ 0.2
13.1 ⫾ 5.7
11.8 ⫾ 2.9

31.8 ⫾ 12.9
26.3 ⫾ 16.6
20.3 ⫾ 7.5
27.9 ⫾ 13.6

81.6 ⫾ 24.0
79.2 ⫾ 24.0
81.6 ⫾ 24.0
81.6 ⫾ 24.0

⬍0.001
⬍0.001
⬍0.001
⬍0.001

a

GNRs, Gram-negative rods.
TAT, turnaround time.
MDx, molecular.
d
For the purposes of these calculations, 3 outliers were excluded from this analysis, including 1 each of a Staphylococcus sp., a Streptococcus sp., and an enteric GNR species, which
were detected and accurately identified by PCR/pyrosequencing only from the final 5-day-time-point aliquot.
e
Electronic medical records from 11 of the physician-ordered, culture-confirmed positive blood culture bottles lacked documentation for the specific time that the Gram stain
result was called to the unit and were therefore excluded from this analysis. For the purposes of these calculations, 5 outliers were excluded from this analysis, including 3
Staphylococcus isolates, with Gram stain times of 61.2, 123.3, and 121.9 h, and 2 Streptococcus isolates, with Gram stain times of 76.2 and 66.6 h. Removal of these 5 outliers was
considered acceptable because the adjusted mean times to Gram stain were not appreciably different from the calculated medians.
b
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antimicrobial susceptibility testing data. Nevertheless, the information provided by our molecular approach was much more specific than the results from the Gram stain, which currently is the
first piece of information provided to physicians that is used to
reassess antibiotic decisions.
This study was also limited in its ability to detect bacterial
growth between 8 and 24 h. Samples that were first detected at 24
h may have been positive sooner but, due to issues of feasibility,
could not have been tested before the 24-hour time point. Similarly, we did not sample daily after 24 h, so the small number that
were not picked up until the 5-day-time-point aliquot may also
have detected sooner. It is therefore possible that the calculated
mean TAT for the molecular approach may in reality be lower
than was calculated (though the 5-day time points were excluded
from the mean TAT, the 3 samples first positive at 24 h were
included).
For streamlining purposes, it is possible to envision developing
a testing algorithm that consisted of batch testing of all newly
inoculated bottles from the previous shift or previous day rather
than processing and testing individual samples one at a time. Automation of some or all of the steps would also help improve
efficiency and reduce hands-on time.
Further research efforts in molecular diagnosis of BSIs should
be directed toward continuing to reduce TATs, detecting bacteria
directly from whole-blood samples, and addressing the issue of
antibiotic resistance. Although a few molecular methods have
been successfully developed to detect the more common antibiotic-resistant organisms seen in the clinical setting (methicillin-resistant S. aureus and vancomycin-resistant Enterococcus spp.),
there is still a large array of genes conferring antibiotic resistance
that are found in many BSI-causing bacteria other than S. aureus
and Enterococcus spp. for which molecular detection methods
would still need to be developed (9).
For the near future, molecular testing won’t be a substitute for
conventional culture. If molecular methods are implemented,
routine culturing will still be needed to enhance sensitivity and
perform susceptibility testing. In summary, the results of this
study clearly show that it was possible to quickly and accurately
diagnose BSIs using a molecular approach. The ability to detect
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Ibrahim et al. in a similar population determined that administration of inadequate or inappropriate antimicrobial treatment was
also associated with increased hospital mortality (13). Rapid detection of BSI has the potential to not only improve patient outcomes due to quicker administration of appropriate antibiotics
but also improve antibiotic stewardship by reducing patient exposures to ineffective or unnecessary broad-spectrum antibiotics
(11, 14). Additionally, the fact that 72.8% of all research samples
from this study tested positive by the molecular approach after
just 5 h of enrichment suggests that a large percentage may actually have been detected using this molecular approach even
sooner.
The biggest limitation of this study was the failure to detect six
culture-confirmed cases (all GNRs) by both the universal and, if
applicable, the enteric-bacterium-specific target. It was determined that the universal and/or target-specific PCR primer sets
used here did recognize DNA made from the purified bacterial
isolates (data not shown). Additionally, the presence of PCR inhibitors was ruled out by performing spiking experiments with the
DNA extracts made from these time point aliquots (data not
shown). It is therefore possible that bacteria in the research blood
culture bottles may have been present below the limit of detection.
It is important to note that no evidence of bacteria was found in
the Gram stains made from the 5-day-time-point aliquots of these
six research blood culture bottles (data not shown). Therefore, it is
also possible that, while the bottles were drawn consecutively, bacteria may have been present in the clinical bottle and not in the
research sample. Alternatively, the research blood culture bottles
could have been incubated longer than 5 days to see if the bacteria
could have been detected. However, this is the standard time used
in the clinical labs, and we wanted to be consistent with their
practice.
Additionally, the groups of primers used here were not designed to determine the species of every etiologic agent known to
cause BSI. For example, the pyrograms generated using the enteric
primers are identical for those for Citrobacter spp. and Enterobacter spp. (12). However, when making decisions about antibiotic
choices, physicians rely heavily on hospital antibiogram data,
which often group several related species together to generate the

PCR Detects Bacteria Sooner than Automated Instrument

and classify 72.8% of the cases after only ⬃11 to 13 h can mean a
dramatic reduction in the number of inappropriate antibiotic
doses given to patients over the course of their treatment. By allowing physicians to tailor their antibiotic treatment of BSI hours
or even days sooner, this molecular approach has the potential to
improve patient outcome and lessen the selective pressures that
promote antibiotic resistance.
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